Interstitial lung disease treated with mycophenolate mofetil
نویسندگان
چکیده
منابع مشابه
Severe Relapsing Goodpasture's Disease Successfully Treated with Mycophenolate Mofetil
Goodpasture's disease is a rare autoimmune disorder characterised by the development of antiglomerular basement membrane autoantibodies, which typically presents with rapidly progressive crescentic glomerulonephritis and pulmonary haemorrhage. Even with aggressive nonspecific immunosuppression and plasma exchange, mortality remains high. We report a case of life-threatening Goodpasture's diseas...
متن کاملMycophenolate mofetil is an effective therapy for connective tissue disease-associated interstitial lung disease
Interstitial lung disease (ILD) is a serious and common complication of different connective tissue diseases (CTD) [1,2] and can lead to significant morbidity and mortality [3]. In Saudi Arabia, CTD-related ILD (CTD-ILD) is the most frequently encountered type of ILD [4]. Treatment aims at improving symptoms and functional status in addition to halting physiological and radiological deteriorati...
متن کاملMycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease.
BACKGROUND Interstitial lung disease (ILD) frequently complicates connective tissue diseases (CTDs). Glucocorticoids and immunomodulatory agents are regarded as mainstays of therapy for CTD-related ILD; however, apart from those studies that have evaluated certain medications for patients with scleroderma, few studies have been performed. In this study, our objectives were to examine the safety...
متن کاملMycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience
BACKGROUND AND OBJECTIVE Interstitial lung disease (ILD) remains the number one cause of mortality in scleroderma (SSc). Our goal was to determine the effectiveness of mycophenolate mofetil (MMF) in treating SSc-ILD in a retrospective study. METHODS A retrospective, computer-assisted search was performed to identify patients with SSc-ILD treated with MMF from 1997 through 2014. We used a nove...
متن کاملUse of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease.
Up to 80% of patients with scleroderma have lung disease, with interstitial lung disease (ILD) being the most common manifestation. Currently, there is no definitive therapy for this condition. The objective of the study is to investigate the use of mycophenolate mofetil (MMF) to treat scleroderma interstitial ILD. We report a retrospective chart review of 17 patients with scleroderma ILD treat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Rheumatology
سال: 2013
ISSN: 1759-4790,1759-4804
DOI: 10.1038/nrrheum.2013.42